3.91
+0.16(+4.27%)
Currency In USD
| Previous Close | 3.75 |
| Open | 3.66 |
| Day High | 4.01 |
| Day Low | 3.65 |
| 52-Week High | 4.12 |
| 52-Week Low | 1.33 |
| Volume | 1.22M |
| Average Volume | 677,341 |
| Market Cap | 116.34M |
| PE | -4.3 |
| EPS | -0.91 |
| Moving Average 50 Days | 2.62 |
| Moving Average 200 Days | 1.99 |
| Change | 0.16 |
If you invested $1000 in Fortress Biotech, Inc. (FBIO) 10 years ago, it would be worth $105.53 as of September 29, 2025 at a share price of $3.91. Whereas If you bought $1000 worth of Fortress Biotech, Inc. (FBIO) shares 5 years ago, it would be worth $66.84 as of September 29, 2025 at a share price of $3.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 02, 2025 12:30 PM GMT
MIAMI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equ
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
GlobeNewswire Inc.
May 30, 2025 2:47 PM GMT
Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up to $4.8 million, plus a 2.5% royalty on future net sales of UNLOXCYT™ (cosibelimab-ipdl)MIAMI, May 30, 2025 (GLOBE NEWSWIR
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
GlobeNewswire Inc.
May 07, 2025 12:00 PM GMT
MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equit